Immune defects in a mouse model of Fanconi anaemia

British Journal of Haematology

Volumn 159, Issue 2, 2012, Pages 246-250

  Holmgren, Sigrid C ^a   Goren, Emily M ^a   Wood, Brent L ^b   Becker, Pamela S ^b   Taylor, Jason A ^a,c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Fanconi anaemia; Human papillomavirus; Immune defects; Vaccination

Indexed keywords

CD19 ANTIGEN; WART VIRUS VACCINE;

B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CANCER IMMUNIZATION; CELL COMPARTMENTALIZATION; DNA REPAIR; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FANCONI ANEMIA; FLOW CYTOMETRY; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; LETTER; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; T LYMPHOCYTE; UTERINE CERVIX CANCER;

ANIMALS; DISEASE MODELS, ANIMAL; FANCONI ANEMIA; MICE; MICE, KNOCKOUT;

EID: 84866856210     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12012     Document Type: Letter

References (9)

1. Didierlaurent, A.M., Morel, S., Lockman, L., Giannini, S.L., Bisteau, M., Carlsen, H., Kielland, A., Vosters, O., Vanderheyde, N., Schiavetti, F., Larocque, D., Van Mechelen, M. & Garcon, N. (2009) AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. Journal of Immunology (Baltimore, Md.: 1950), 183, 6186-6197.
2. Dobbs, A.K., Bosompem, A., Coustan-Smith, E., Tyerman, G., Saulsbury, F.T. & Conley, M.E. (2011) Agammaglobulinemia associated with BCR(-) B cells and enhanced expression of CD19. Blood, 118, 1828-1837.
3. Fagerlie, S.R. & Bagby, G.C. (2006) Immune defects in fanconi anemia. Critical Reviews in Immunology, 26, 81-96.
4. Giannini, S.L., Hanon, E., Moris, P., Van Mechelen, M., Morel, S., Dessy, F., Fourneau, M.A., Colau, B., Suzich, J., Losonksy, G., Martin, M.T., Dubin, G. & Wettendorff, M.A. (2006) Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only. Vaccine, 24, 5937-5949.
5. Kutler, D.I., Auerbach, A.D., Satagopan, J., Giampietro, P.F., Batish, S.D., Huvos, A.G., Goberdhan, A., Shah, J.P. & Singh, B. (2003) High incidence of head and neck squamous cell carcinoma in patients with fanconi anemia. Archives of Otolaryngology - Head & Neck Surgery, 129, 106-112.
6. Park, J.W., Pitot, H.C., Strati, K., Spardy, N., Duensing, S., Grompe, M. & Lambert, P.F. (2010) Deficiencies in the fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer. Cancer Research, 70, 9959-9968.
7. Roxo, Jr, F., Arruda, L.K., Nagao, A.T., Carneiro-Sampaio, M.M. & Ferriani, V.P. (2001) Allergic and immunologic parameters in patients with fanconi's anemia. International Archives of Allergy and Immunology, 125, 349-355.
8. Sehr, P., Muller, M., Hopfl, R., Widschwendter, A. & Pawlita, M. (2002) HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. Journal of Virological Methods, 106, 61-70.
9. Sejas, D.P., Rani, R., Qiu, Y., Zhang, X., Fagerlie, S.R., Nakano, H., Williams, D.A. & Pang, Q. (2007) Inflammatory reactive oxygen species-mediated hemopoietic suppression in fancc-deficient mice. Journal of Immunology (Baltimore, Md.: 1950), 178, 5277-5287.